TapewireFind a company

person · Reporting owner

Pfeil Keith W

Disclosed activity across 2 companies

Tapewire entity
68881
SEC CIK
0001752014

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CSS INDUSTRIES INCCSS · Entity 150987Exec. VP and CFOMay 29, 2019May 31, 2019
GLOBUS MEDICAL INCGMED · Entity 3496Director · President, CEOJanuary 21, 2026January 23, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CSS INDUSTRIES INC

Report date May 29, 2019 · Filed May 31, 2019

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock ($.10 par value)SEC Table I · non-derivativeDirect2,851 Ending reported balance After 2019-05-31 transaction · row 4
4 source rows · reconciled sequence

Row 1 · 2019-05-29 · Exercise / conversion · Acquired 687 · Balance 2,678

F1: Reflects the automatic redemption of restricted stock units (RSUs) upon the satisfaction of service-based vesting conditions. Each RSU was redeemed for one share of Issuer common stock.

Row 2 · 2019-05-29 · Tax withholding · Disposed 189 · Balance 2,489

F2: Reflects shares withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs.

Row 3 · 2019-05-31 · Exercise / conversion · Acquired 500 · Balance 2,989

F1: Reflects the automatic redemption of restricted stock units (RSUs) upon the satisfaction of service-based vesting conditions. Each RSU was redeemed for one share of Issuer common stock.

Row 4 · 2019-05-31 · Tax withholding · Disposed 138 · Balance 2,851

F2: Reflects shares withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs.

Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct2,063 Reported balance After 2019-05-29 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2019-05-29 · Exercise / conversion · Disposed 687 · Balance 2,063

F1: Reflects the automatic redemption of restricted stock units (RSUs) upon the satisfaction of service-based vesting conditions. Each RSU was redeemed for one share of Issuer common stock.

F3: Subject to the satisfaction of service-based vesting conditions, 25% of the RSUs vest on each of the 1st, 2nd, 3rd and 4th anniversaries of the grant date, May 29, 2018. Upon vesting, RSUs are automatically converted into shares of Issuer common stock on a 1-to-1 basis.

Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct500 Reported balance After 2019-05-31 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2019-05-31 · Exercise / conversion · Disposed 500 · Balance 500

F1: Reflects the automatic redemption of restricted stock units (RSUs) upon the satisfaction of service-based vesting conditions. Each RSU was redeemed for one share of Issuer common stock.

F4: Subject to the satisfaction of service-based vesting conditions, 50% of the RSUs vest on each of the 3rd and 4th anniversaries of the grant date, May 31, 2016. Upon vesting, RSUs are automatically converted into shares of Issuer common stock on a 1-to-1 basis.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the automatic redemption of restricted stock units (RSUs) upon the satisfaction of service-based vesting conditions. Each RSU was redeemed for one share of Issuer common stock.

F2: Reflects shares withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs.

F3: Subject to the satisfaction of service-based vesting conditions, 25% of the RSUs vest on each of the 1st, 2nd, 3rd and 4th anniversaries of the grant date, May 29, 2018. Upon vesting, RSUs are automatically converted into shares of Issuer common stock on a 1-to-1 basis.

F4: Subject to the satisfaction of service-based vesting conditions, 50% of the RSUs vest on each of the 3rd and 4th anniversaries of the grant date, May 31, 2016. Upon vesting, RSUs are automatically converted into shares of Issuer common stock on a 1-to-1 basis.

GLOBUS MEDICAL INC

Report date January 21, 2026 · Filed January 23, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $94.15 · Expires 2036-01-21Direct100,000 Reported balance After 2026-01-21 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-01-21 · Grant · Acquired 100,000 · Balance 100,000

F1: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, and then 1/48 of the options vesting each month thereafter.

Filing footnotes · ownership attribution and instrument terms

F1: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, and then 1/48 of the options vesting each month thereafter.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
January 21, 2026 Filed Jan 23, 2026 22:10 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 100,000 $0.00 Strike: $94.15 $0.00
Disclosure

SEC source: 0001193125-26-021263 · ownership.xml · derivative · entry 1

Pfeil Keith W · CIK 0001752014 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Class A Common Stock · 100,000 shares

Expires 2036-01-21

F1 · derivative.exercise_date: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, and then 1/48 of the options vesting each month thereafter.

Read SEC document
July 18, 2025 Filed Aug 27, 2025 22:10 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 40,000 $0.00 Strike: $56.34 $0.00
Disclosure

SEC source: 0000950170-25-111762 · ownership.xml · derivative · entry 1

Pfeil Keith W · CIK 0001752014 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Class A Common Stock · 40,000 shares

Expires 2035-07-18

F1 · derivative.exercise_date: These options were granted on July 18, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on July 18, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
January 23, 2025 Filed Mar 28, 2025 23:02 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 60,000 $0.00 Strike: $92.42 $0.00
Disclosure

SEC source: 0000950170-25-047033 · ownership.xml · derivative · entry 1

Pfeil Keith W · CIK 0001752014 · COO, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Class A Common Stock · 60,000 shares

Expires 2035-01-23

F1 · derivative.exercise_date: These options were granted on January 23, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
January 10, 2025 Filed Jan 14, 2025 21:12 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 8,334 $0.00 Strike: $53.27 $0.00
Disclosure

SEC source: 0000950170-25-005353 · ownership.xml · derivative · entry 6

Pfeil Keith W · CIK 0001752014 · COO, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 833

Underlying: Class A Common Stock · 8,334 shares

Expires 2030-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options were granted on January 22, 2020 and are fully vested.

Read SEC document
January 10, 2025 Filed Jan 14, 2025 21:12 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 5,833 $0.00 Strike: $49.65 $0.00
Disclosure

SEC source: 0000950170-25-005353 · ownership.xml · derivative · entry 5

Pfeil Keith W · CIK 0001752014 · COO, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 5,833 shares

Expires 2029-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options were granted on September 3, 2019 and are fully vested.

Read SEC document
January 10, 2025 Filed Jan 14, 2025 21:12 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 1,666 $89.17 $148,557.22
Disclosure

SEC source: 0000950170-25-005353 · ownership.xml · nonDerivative · entry 4

Pfeil Keith W · CIK 0001752014 · COO, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated December 15, 2023 executed by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.69 to $89.63, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.

Read SEC document
January 10, 2025 Filed Jan 14, 2025 21:12 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 12,501 $88.17 $1,102,213.17
Disclosure

SEC source: 0000950170-25-005353 · ownership.xml · nonDerivative · entry 3

Pfeil Keith W · CIK 0001752014 · COO, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,666

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated December 15, 2023 executed by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.60 to $88.55, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
January 10, 2025 Filed Jan 14, 2025 21:12 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 8,334 $53.27 $443,952.18
Disclosure

SEC source: 0000950170-25-005353 · ownership.xml · nonDerivative · entry 2

Pfeil Keith W · CIK 0001752014 · COO, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,167

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 10, 2025 Filed Jan 14, 2025 21:12 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 5,833 $49.65 $289,608.45
Disclosure

SEC source: 0000950170-25-005353 · ownership.xml · nonDerivative · entry 1

Pfeil Keith W · CIK 0001752014 · COO, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,833

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 26, 2024 Filed Jan 30, 2024 21:39 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 60,000 $0.00 Strike: $53.75 $0.00
Disclosure

SEC source: 0000950170-24-008889 · ownership.xml · derivative · entry 1

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Class A Common Stock · 60,000 shares

Expires 2034-01-26

F1 · derivative.exercise_date: These options were granted on January 26, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
October 10, 2023 Filed Oct 19, 2023 21:06 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 5,000 $0.00 Strike: $53.02 $0.00
Disclosure

SEC source: 0001209191-23-053189 · doc4.xml · derivative · entry 1

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Class A Common Stock · 5,000 shares

Expires 2033-09-01

F1 · derivative.exercise_date: These options were granted on October 10, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on September 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
February 02, 2023 Filed Feb 6, 2023 21:52 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 15,000 $0.00 Strike: $53.27 $0.00
Disclosure

SEC source: 0001209191-23-007323 · doc4.xml · derivative · entry 5

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,167

Underlying: Class A Common Stock · 15,000 shares

Expires 2030-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options were granted on January 22, 2020 and are fully vested.

Read SEC document
February 02, 2023 Filed Feb 6, 2023 21:52 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 14,167 $0.00 Strike: $49.65 $0.00
Disclosure

SEC source: 0001209191-23-007323 · doc4.xml · derivative · entry 4

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,833

Underlying: Class A Common Stock · 14,167 shares

Expires 2029-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted on September 3, 2019 and are fully vested.

Read SEC document
February 02, 2023 Filed Feb 6, 2023 21:52 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 29,167 $77.57 $2,262,425.86
Disclosure

SEC source: 0001209191-23-007323 · doc4.xml · nonDerivative · entry 3

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.50 to $77.885, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
February 02, 2023 Filed Feb 6, 2023 21:52 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 15,000 $53.27 $799,050.00
Disclosure

SEC source: 0001209191-23-007323 · doc4.xml · nonDerivative · entry 2

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,167

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 02, 2023 Filed Feb 6, 2023 21:52 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 14,167 $49.65 $703,391.55
Disclosure

SEC source: 0001209191-23-007323 · doc4.xml · nonDerivative · entry 1

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,167

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 26, 2023 Filed Feb 27, 2023 21:52 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 40,000 $0.00 Strike: $75.18 $0.00
Disclosure

SEC source: 0001209191-23-013219 · doc4.xml · derivative · entry 1

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Class A Common Stock · 40,000 shares

Expires 2033-01-26

F1 · derivative.exercise_date: These options were granted on January 26, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
January 27, 2022 Filed Jan 31, 2022 21:46 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 40,000 $0.00 Strike: $63.68 $0.00
Disclosure

SEC source: 0001209191-22-005586 · doc4.xml · derivative · entry 1

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Class A Common Stock · 40,000 shares

Expires 2032-01-27

F1 · derivative.exercise_date: These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
August 19, 2021 Filed Aug 23, 2021 20:41 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 833 $0.00 Strike: $53.27 $0.00
Disclosure

SEC source: 0001209191-21-052968 · doc4.xml · derivative · entry 3

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,334

Underlying: Class A Common Stock · 833 shares

Expires 2030-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
August 19, 2021 Filed Aug 23, 2021 20:41 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 833 $76.13 $63,416.29
Disclosure

SEC source: 0001209191-21-052968 · doc4.xml · nonDerivative · entry 2

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

Read SEC document
August 19, 2021 Filed Aug 23, 2021 20:41 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 833 $53.27 $44,373.91
Disclosure

SEC source: 0001209191-21-052968 · doc4.xml · nonDerivative · entry 1

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 833

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 19, 2021 Filed Feb 6, 2023 21:43 UTC Amendment GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 0 $0.00 Strike: $53.27 $0.00
Disclosure

SEC source: 0001209191-23-007310 · doc4a.xml · derivative · entry 4

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,167

Underlying: Class A Common Stock · 0 shares

Expires 2030-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

F4 · balance_after: The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a transaction that occurred on August 19, 2021 as exercising a total of 833 options granted on January 22, 2020 when in fact such options were granted on September 3, 2019. As a result of this administrative error, the number of derivative securities beneficially owned by the reporting person following the corrected transaction reflects an increase by 833 in the number of options granted in 2020 and a decrease by 833 in the number of options granted in 2019.

Read SEC document
August 19, 2021 Filed Feb 6, 2023 21:43 UTC Amendment GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 833 $0.00 Strike: $49.65 $0.00
Disclosure

SEC source: 0001209191-23-007310 · doc4a.xml · derivative · entry 3

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Class A Common Stock · 833 shares

Expires 2029-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on August 19, 2021 at an exercise price of $53.27 when in fact such options were exercised at a price of $49.65.

F3 · derivative.exercise_date: These options were granted on September 3, 2019 and are fully vested.

F4 · balance_after: The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a transaction that occurred on August 19, 2021 as exercising a total of 833 options granted on January 22, 2020 when in fact such options were granted on September 3, 2019. As a result of this administrative error, the number of derivative securities beneficially owned by the reporting person following the corrected transaction reflects an increase by 833 in the number of options granted in 2020 and a decrease by 833 in the number of options granted in 2019.

Read SEC document
August 19, 2021 Filed Feb 6, 2023 21:43 UTC Amendment GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 833 $76.13 $63,416.29
Disclosure

SEC source: 0001209191-23-007310 · doc4a.xml · nonDerivative · entry 2

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

Read SEC document
August 19, 2021 Filed Feb 6, 2023 21:43 UTC Amendment GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 833 $49.65 $41,358.45
Disclosure

SEC source: 0001209191-23-007310 · doc4a.xml · nonDerivative · entry 1

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 833

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The original Form 4, filed on August 23, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on August 19, 2021 at an exercise price of $53.27 when in fact such options were exercised at a price of $49.65.

Read SEC document
August 02, 2021 Filed Aug 3, 2021 22:14 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 833 $0.00 Strike: $53.27 $0.00
Disclosure

SEC source: 0001209191-21-049452 · doc4.xml · derivative · entry 3

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,167

Underlying: Class A Common Stock · 833 shares

Expires 2030-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
August 02, 2021 Filed Aug 3, 2021 22:14 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 833 $83.24 $69,338.92
Disclosure

SEC source: 0001209191-21-049452 · doc4.xml · nonDerivative · entry 2

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.24 to $83.25, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
August 02, 2021 Filed Aug 3, 2021 22:14 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 833 $53.27 $44,373.91
Disclosure

SEC source: 0001209191-21-049452 · doc4.xml · nonDerivative · entry 1

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 833

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 19, 2021 Filed Jul 20, 2021 20:20 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 834 $0.00 Strike: $49.65 $0.00
Disclosure

SEC source: 0001209191-21-047369 · doc4.xml · derivative · entry 3

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,833

Underlying: Class A Common Stock · 834 shares

Expires 2029-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on September 3, 2019, and vest over a four-year period with one-fourth (1/4) of the options vesting on August 19, 2020 and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
July 19, 2021 Filed Jul 20, 2021 20:20 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 834 $78.25 $65,260.50
Disclosure

SEC source: 0001209191-21-047369 · doc4.xml · nonDerivative · entry 2

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

Read SEC document
July 19, 2021 Filed Jul 20, 2021 20:20 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 834 $49.65 $41,408.10
Disclosure

SEC source: 0001209191-21-047369 · doc4.xml · nonDerivative · entry 1

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 834

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 21:14 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 833 $0.00 Strike: $53.27 $0.00
Disclosure

SEC source: 0001209191-21-045571 · doc4.xml · derivative · entry 3

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Class A Common Stock · 833 shares

Expires 2030-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 21:14 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 833 $77.43 $64,499.19
Disclosure

SEC source: 0001209191-21-045571 · doc4.xml · nonDerivative · entry 2

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

Read SEC document
July 01, 2021 Filed Jul 6, 2021 21:14 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 833 $53.27 $44,373.91
Disclosure

SEC source: 0001209191-21-045571 · doc4.xml · nonDerivative · entry 1

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 833

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 25, 2021 Filed Jun 28, 2021 20:52 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 14,167 $0.00 Strike: $53.27 $0.00
Disclosure

SEC source: 0001209191-21-043495 · doc4.xml · derivative · entry 5

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,833

Underlying: Class A Common Stock · 14,167 shares

Expires 2030-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
June 25, 2021 Filed Jun 28, 2021 20:52 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 13,312 $0.00 Strike: $49.65 $0.00
Disclosure

SEC source: 0001209191-21-043495 · doc4.xml · derivative · entry 4

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,667

Underlying: Class A Common Stock · 13,312 shares

Expires 2029-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted on September 3, 2019, and vest over a four-year period with one-fourth (1/4) of the options vesting on August 19, 2020 and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
June 25, 2021 Filed Jun 28, 2021 20:52 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 27,479 $75.04 $2,062,024.16
Disclosure

SEC source: 0001209191-21-043495 · doc4.xml · nonDerivative · entry 3

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.25, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Read SEC document
June 25, 2021 Filed Jun 28, 2021 20:52 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 14,167 $53.27 $754,676.09
Disclosure

SEC source: 0001209191-21-043495 · doc4.xml · nonDerivative · entry 2

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,167

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 25, 2021 Filed Jun 28, 2021 20:52 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 13,312 $49.65 $660,940.80
Disclosure

SEC source: 0001209191-21-043495 · doc4.xml · nonDerivative · entry 1

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,312

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 05, 2021 Filed May 7, 2021 20:17 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative 5,021 $0.00 Strike: $49.65 $0.00
Disclosure

SEC source: 0001209191-21-030906 · doc4.xml · derivative · entry 3

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,979

Underlying: Class A Common Stock · 5,021 shares

Expires 2029-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on September 3, 2019, and vest over a four-year period with one-fourth (1/4) of the options vesting on August 19, 2020 and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
May 05, 2021 Filed May 7, 2021 20:17 UTC GLOBUS MEDICAL INC GMED · Entity 3496 SaleClass A Common Stock 5,021 $75.00 $376,575.00
Disclosure

SEC source: 0001209191-21-030906 · doc4.xml · nonDerivative · entry 2

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.

Read SEC document
May 05, 2021 Filed May 7, 2021 20:17 UTC GLOBUS MEDICAL INC GMED · Entity 3496 Exercise / conversionClass A Common Stock 5,021 $49.65 $249,292.65
Disclosure

SEC source: 0001209191-21-030906 · doc4.xml · nonDerivative · entry 1

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,021

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 14, 2021 Filed Jan 19, 2021 21:48 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 40,000 $0.00 Strike: $65.05 $0.00
Disclosure

SEC source: 0001209191-21-004036 · doc4.xml · derivative · entry 1

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Class A Common Stock · 40,000 shares

Expires 2031-01-14

F1 · derivative.exercise_date: These options were granted on January 14, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
January 22, 2020 Filed Jan 24, 2020 21:42 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 40,000 $0.00 Strike: $53.27 $0.00
Disclosure

SEC source: 0001209191-20-004852 · doc4.xml · derivative · entry 1

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Class A Common Stock · 40,000 shares

Expires 2030-01-22

F1 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
September 03, 2019 Filed Sep 5, 2019 20:57 UTC GLOBUS MEDICAL INC GMED · Entity 3496 GrantStock Option (Right to Buy Class A Common Stock) · Derivative 40,000 $0.00 Strike: $49.65 $0.00
Disclosure

SEC source: 0001209191-19-048566 · doc4.xml · derivative · entry 1

Pfeil Keith W · CIK 0001752014 · SVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Class A Common Stock · 40,000 shares

Expires 2029-09-03

F1 · derivative.exercise_date: These options were granted on September 3, 2019, and vest over a four-year period with one-fourth (1/4) of the options vesting on August 19, 2020 and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Read SEC document
May 31, 2019 Filed May 31, 2019 16:27 UTC CSS INDUSTRIES INC CSS · Entity 150987 Exercise / conversionRestricted Stock Units · Derivative 500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000020629-19-000065 · wf-form4_155933441947040.xml · derivative · entry 6

Pfeil Keith W · CIK 0001752014 · Exec. VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

Underlying: Common Stock ($.10 par value) · 500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects the automatic redemption of restricted stock units (RSUs) upon the satisfaction of service-based vesting conditions. Each RSU was redeemed for one share of Issuer common stock.

F4 · derivative.exercise_date: Subject to the satisfaction of service-based vesting conditions, 50% of the RSUs vest on each of the 3rd and 4th anniversaries of the grant date, May 31, 2016. Upon vesting, RSUs are automatically converted into shares of Issuer common stock on a 1-to-1 basis.

F4 · derivative.expiration_date: Subject to the satisfaction of service-based vesting conditions, 50% of the RSUs vest on each of the 3rd and 4th anniversaries of the grant date, May 31, 2016. Upon vesting, RSUs are automatically converted into shares of Issuer common stock on a 1-to-1 basis.

Read SEC document
May 31, 2019 Filed May 31, 2019 16:27 UTC CSS INDUSTRIES INC CSS · Entity 150987 Tax withholdingCommon Stock ($.10 par value) 138 $6.15 $848.70
Disclosure

SEC source: 0000020629-19-000065 · wf-form4_155933441947040.xml · nonDerivative · entry 4

Pfeil Keith W · CIK 0001752014 · Exec. VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,851

F2 · kind: Reflects shares withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs.

Read SEC document
May 31, 2019 Filed May 31, 2019 16:27 UTC CSS INDUSTRIES INC CSS · Entity 150987 Exercise / conversionCommon Stock ($.10 par value) 500 $0.00 $0.00
Disclosure

SEC source: 0000020629-19-000065 · wf-form4_155933441947040.xml · nonDerivative · entry 3

Pfeil Keith W · CIK 0001752014 · Exec. VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects the automatic redemption of restricted stock units (RSUs) upon the satisfaction of service-based vesting conditions. Each RSU was redeemed for one share of Issuer common stock.

Read SEC document
May 29, 2019 Filed May 31, 2019 16:27 UTC CSS INDUSTRIES INC CSS · Entity 150987 Exercise / conversionRestricted Stock Units · Derivative 687 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000020629-19-000065 · wf-form4_155933441947040.xml · derivative · entry 5

Pfeil Keith W · CIK 0001752014 · Exec. VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,063

Underlying: Common Stock ($.10 par value) · 687 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects the automatic redemption of restricted stock units (RSUs) upon the satisfaction of service-based vesting conditions. Each RSU was redeemed for one share of Issuer common stock.

F3 · derivative.exercise_date: Subject to the satisfaction of service-based vesting conditions, 25% of the RSUs vest on each of the 1st, 2nd, 3rd and 4th anniversaries of the grant date, May 29, 2018. Upon vesting, RSUs are automatically converted into shares of Issuer common stock on a 1-to-1 basis.

F3 · derivative.expiration_date: Subject to the satisfaction of service-based vesting conditions, 25% of the RSUs vest on each of the 1st, 2nd, 3rd and 4th anniversaries of the grant date, May 29, 2018. Upon vesting, RSUs are automatically converted into shares of Issuer common stock on a 1-to-1 basis.

Read SEC document
May 29, 2019 Filed May 31, 2019 16:27 UTC CSS INDUSTRIES INC CSS · Entity 150987 Tax withholdingCommon Stock ($.10 par value) 189 $6.28 $1,186.92
Disclosure

SEC source: 0000020629-19-000065 · wf-form4_155933441947040.xml · nonDerivative · entry 2

Pfeil Keith W · CIK 0001752014 · Exec. VP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,489

F2 · kind: Reflects shares withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.